THC TENET HEALTHCARE CORP
Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 70318 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.2%
TTM net income YoY114.1%
TTM EPS YoY133.1%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR83.5%
Margins
Gross margin—
Operating margin24.4%
Net margin13.1%
FCF margin15.0%
EBITDA margin28.4%
Returns
ROE61.3%
ROA9.5%
ROIC (approx.)28.2%
Asset turnover0.73x
Leverage & solvency
Liabilities / assets69.6%
Debt / equity2.43x
Current ratio1.58x
Interest coverage6.61x
Cash quality & payout
Operating cash flow / net income1.46x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue4.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q3*2026-09-30 | 2026Q2*2026-06-30 | 2026Q1*2026-03-31 | 2025Q4*2025-12-31 | 2025Q3*2025-09-30 | 2025Q2*2025-06-30 | 2025Q1*2025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $5.63B | $5.63B | $5.37B | $5.53B | $5.29B | $5.27B | $5.22B | $5.07B |
| Operating income | $1.75B | $1.50B | $1.30B | $853.00M | $889.00M | $823.00M | $943.00M | $821.00M |
| Interest expense | $203.00M | $204.00M | $205.00M | $205.00M | $206.00M | $206.00M | $204.00M | $203.00M |
| Pretax income | — | $1.34B | $1.13B | $681.00M | $712.00M | $642.00M | $765.00M | $655.00M |
| Income tax | $360.00M | $295.00M | $226.00M | $37.00M | $133.00M | $120.00M | $143.00M | $83.00M |
| Net income | $1.00B | $826.00M | $702.00M | $371.00M | $342.00M | $288.00M | $406.00M | $318.00M |
| EBITDA | $1.97B | $1.72B | $1.52B | $1.08B | $1.11B | $1.03B | $1.15B | $1.01B |
| EPS (basic) | 12.48 | 9.89 | 8.09 | — | 3.89 | 3.16 | 4.31 | — |
| EPS (diluted) | 12.41 | 9.84 | 8.01 | — | 3.86 | 3.14 | 4.27 | — |
| Weighted avg. shares (diluted) | 80.60M | 83.96M | 87.60M | — | 88.61M | 91.79M | 95.02M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $2.67B | $2.17B | $2.97B | $2.88B | $2.98B | $2.62B | $3.00B | $3.02B |
| Receivables | $2.60B | $2.61B | $2.60B | $2.56B | $2.52B | $2.53B | $2.62B | $2.54B |
| Inventory | $340.00M | $338.00M | $343.00M | $348.00M | $346.00M | $338.00M | $344.00M | $346.00M |
| Current assets | $8.43B | $7.83B | $8.36B | $7.85B | $7.81B | $7.30B | $7.91B | $7.68B |
| PP&E, net | $6.29B | $6.26B | $6.25B | $6.32B | $6.09B | $6.02B | $5.99B | $6.05B |
| Goodwill | $11.64B | $11.44B | $11.39B | $11.20B | $11.16B | $10.94B | $10.79B | $10.69B |
| Intangibles | $1.23B | $1.28B | $1.32B | $1.35B | $1.35B | $1.37B | $1.40B | $1.40B |
| Total assets | $31.59B | $30.68B | $31.20B | $29.68B | $29.42B | $28.70B | $29.24B | $28.94B |
| Current liabilities | $5.32B | $5.57B | $6.15B | $4.46B | $4.56B | $4.27B | $4.45B | $4.31B |
| Short-term debt | $164.00M | $160.00M | $81.00M | $79.00M | $85.00M | $84.00M | $88.00M | $92.00M |
| Long-term debt | $13.08B | $13.09B | $13.13B | $13.09B | $13.10B | $13.09B | $13.08B | $13.08B |
| Total debt | $13.24B | $13.25B | $13.21B | $13.17B | $13.19B | $13.18B | $13.17B | $13.17B |
| Total liabilities | $22.00B | $21.98B | $22.35B | $20.70B | $20.72B | $20.40B | $20.58B | $20.39B |
| Shareholders' equity | $5.44B | $4.66B | $4.81B | $4.22B | $4.01B | $3.75B | $4.18B | $4.17B |
| Net debt | $10.57B | $11.08B | $10.24B | $10.29B | $10.21B | $10.55B | $10.17B | $10.15B |
| Cash flow statement | ||||||||
| Operating cash flow | $1.28B | $585.00M | $1.64B | $731.00M | $1.06B | $936.00M | $815.00M | -$331.00M |
| Capital expenditure | $198.00M | $168.00M | $180.00M | $364.00M | $280.00M | $193.00M | $173.00M | $330.00M |
| Free cash flow | $1.08B | $417.00M | $1.46B | $367.00M | $778.00M | $743.00M | $642.00M | -$661.00M |
| Investing cash flow | -$298.00M | -$203.00M | -$317.00M | -$389.00M | -$385.00M | -$314.00M | -$187.00M | -$372.00M |
| Financing cash flow | -$479.00M | -$1.18B | -$1.24B | -$434.00M | -$323.00M | -$996.00M | -$648.00M | -$372.00M |
| Depreciation & amortization | $217.00M | $215.00M | $229.00M | $231.00M | $218.00M | $208.00M | $206.00M | $193.00M |
| Stock-based compensation | $35.00M | $44.00M | $25.00M | $25.00M | $38.00M | $20.00M | $21.00M | $15.00M |
| Share buybacks | $255.00M | $1.04B | $318.00M | $198.00M | $93.00M | $747.00M | $348.00M | $0 |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.